Analyzing...
Loading company...
Nothing flagged for monitoring
“Operates in Pharmaceuticals — Formulations & API.”
₹1,551 Cr revenue.
COGS 52.3%, employees 18.1%.
“we are confident, and we are targeting minimum of 20% EBITDA growth.”
“Looking at our current day, two hundred hour growth is nothing actually for this company.”
“Revenue from operations for Q3 FY26 was INR858 crores, grown up by 11% year on year.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 9.5%▼ | 10.5% |
| ROCE | 16.5%▲ | 13.8% |
| Net Margin | 3.6%▼ | 8.7% |
| EBITDA Margin | 14.3%▼ | 16.0% |
| Debt To Equity | 0.56x▲ | 0.21x |
| Rev Growth 3yr | 3.2%▼ | 5.8% |
| EPS Growth 3yr | -19.3%▼ | 3.6% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,126 Cr +37.0% | ₹1,551 Cr +13.3% | ₹1,370 Cr -3.6% | ₹1,421 Cr +0.6% | ₹1,413 Cr +3.8% | ₹1,362 Cr +15.5% | ₹1,179 Cr +13.5% | ₹1,039 Cr |
| Other Income | ₹22 Cr +47.4% | ₹15 Cr +34.1% | ₹11 Cr +71.5% | ₹6 Cr -41.1% | ₹11 Cr +29.7% | ₹8 Cr -17.1% | ₹10 Cr +16.3% | ₹9 Cr |
| Total Income | ₹2,147 Cr +37.1% | ₹1,566 Cr +13.4% | ₹1,381 Cr -3.3% | ₹1,427 Cr +0.3% | ₹1,424 Cr +3.9% | ₹1,370 Cr +15.2% | ₹1,189 Cr +13.5% | ₹1,048 Cr |
| COGS | ₹1,038 Cr +27.9% | ₹812 Cr +6.9% | ₹760 Cr -8.9% | ₹834 Cr +5.1% | ₹793 Cr +14.2% | ₹695 Cr +14.8% | ₹605 Cr +11.4% | ₹543 Cr |
| ₹1,961 Cr +29.3% | ₹1,517 Cr +7.0% | ₹1,418 Cr -5.5% | ₹1,500 Cr +9.5% | ₹1,370 Cr +11.9% | ₹1,225 Cr +11.8% | ₹1,095 Cr +10.7% | ₹989 Cr | |
| Profit Before Tax | ₹142 Cr +220.6% | ₹44 Cr ↑ Recovery | (₹55 Cr) +60.3% | (₹138 Cr) ↓ Decline | ₹53 Cr -60.9% | ₹137 Cr +45.2% | ₹94 Cr +59.8% | ₹59 Cr |
| Exceptional Items | (₹45 Cr) -796.4% | (₹5 Cr) +71.4% | (₹17 Cr) +73.2% | (₹65 Cr) | ₹0.00 Cr +100.0% | (₹9 Cr) | ₹0.00 Cr | ₹0.00 Cr |
| ₹46 Cr +281.7% | ₹12 Cr ↑ Recovery | (₹25 Cr) -59.6% | (₹16 Cr) ↓ Decline | ₹8 Cr -74.1% | ₹32 Cr +167.5% | ₹12 Cr +499.4% | ₹2 Cr | |
| Net Profit | ₹96 Cr +197.8% | ₹32 Cr ↑ Recovery | (₹30 Cr) +75.7% | (₹122 Cr) ↓ Decline | ₹45 Cr -56.9% | ₹104 Cr +27.3% | ₹82 Cr +44.3% | ₹57 Cr |
| Profit (Owners) | ₹77 Cr +251.1% | ₹22 Cr ↑ Recovery | (₹36 Cr) +70.4% | (₹121 Cr) ↓ Decline | ₹41 Cr -56.8% | ₹95 Cr +36.5% | ₹70 Cr +43.7% | ₹49 Cr |
| Minority Interest | ₹19 Cr +85.5% | ₹10 Cr +65.9% | ₹6 Cr ↑ Recovery | (₹0.82 Cr) ↓ Decline | ₹4 Cr -57.7% | ₹9 Cr -25.8% | ₹12 Cr +47.8% | ₹8 Cr |
| Other Comprehensive Income | ₹96 Cr ↑ Recovery | (₹22 Cr) +66.8% | (₹65 Cr) -149.2% | (₹26 Cr) +75.9% | (₹109 Cr) ↓ Decline | ₹64 Cr ↑ Recovery | (₹32 Cr) +40.8% | (₹54 Cr) |
| EPS | ₹2.41 | ₹0.87 | (₹1.44) | (₹4.86) | ₹1.66 | ₹3.84 | ₹2.81 | ₹1.97 |
| Diluted Shares | ₹44 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹24 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Viyash Scientific Limited has informed the Exchange regarding a press release dated Jun 08, 2026.
Viyash Scientific Limited has informed the Exchange about General Updates-Acquisition
Viyash Scientific Limited has informed the Exchange about Copy of Newspaper Publication
Viyash Scientific Limited has informed the Exchange about Transcript
Viyash Scientific Limited has informed the Exchange about Schedule of meet
Viyash Scientific Limited has informed the Exchange regarding Appointment of Appointment of Directors as Non- Executive Director of the company w.e.f. April 22, 2026.
Viyash Scientific Limited has informed the Exchange regarding Outcome of Board Meeting held on April 22, 2026.
Viyash Scientific Limited has informed the Exchange about Change in Domain name and website of the Company
Viyash Scientific Limited has informed the Exchange regarding 'Clarification letter on Intimation submitted on March 30, 2026'.
Viyash Scientific Limited has informed the Exchange regarding 'Allotment of Equity Shares under Sequent Scientific Limited Employee Stock Option Plan 2020'.
Viyash Scientific Limited has informed the Exchange about Copy of Newspaper Publication
Viyash Scientific Limited has informed the Exchange regarding Notice of Postal Ballot
Viyash Scientific Limited has informed the Exchange about Transcript
Viyash Scientific Limited has informed the Exchange about Copy of Newspaper Publication-Financial Results Q3 FY26
Viyash Scientific Limited has informed the Exchange about Link of Recording
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
No dividend history available for this company.